comparemela.com

Latest Breaking News On - John theurer cancer center - Page 5 : comparemela.com

The Evolving Treatment Landscape of Leukemia

James K. McCloskey, MD, a specialist in leukemia, discusses how the treatment landscape has changed in recent years.

Jamesk mccloskeyGloria lesliePeer exchangeHackensack university medical centerJohn theurer cancer centerLeukemia divisionHackensack university medical

Recent Data from ASH 2023 in Leukemia

Following ASH 2023, a hematologist-oncologist discusses recent updates on approved and emerging therapies for patients with leukemia, highlighting the TRANSFORM-1 trial looking at navitoclax plus ruxolitinib.

Jamesk mccloskeyGloria leslieJohn theurer cancer centerPeer exchangeHackensack university medical centerLeukemia divisionHackensack university medical

Liso-Cel Maintains Longer-Term Responses in Pretreated Relapsed/Refractory CLL/SLL

Tatyana Feldman, MD, highlights updated data for liso-cel in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

New jerseyUnited statesTatyana feldmanJohn theurer cancer centerIso celCar tRelapsed refractory chronic lymphocytic leukemia small lymphomaPhase 1 2 transcend cll 004 trial nct03331198

Immunocompromised population shown to react well to COVID-19 vaccine

Immunocompromised population shown to react well to COVID-19 vaccine
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Jeffrey boscampDavid perlinElizabeth titovaHackensack meridian school of medicineHackensack meridian health centerJohn theurer cancer centerQuest diagnosticsMicrobiology spectrumHackensack meridian schoolFair lawnHackensack meridian healthTheurer cancer center

Dr Goy on the Rationale for Launching the ZUMA-18 Trial in Relapsed/Refractory MCL

Andre Goy, MD, discusses the evaluation of brexu-cel in the ZUMA-2 and expanded access ZUMA-18 trials in relapsed/refractory mantle cell lymphoma.

United statesAndre goyHackensack meridian health oncology care transformation servicesJohn theurer cancer centerLymphoma divisionHackensack university medical centerJohn theurer cancer centerHackensack university medical centerOnclive tvMantle cell lymphoma

vimarsana © 2020. All Rights Reserved.